IL7 and neoplasm: Since direct injection of IL-7 as an adjuvant has been proven to be safe and effective, IL-7-cotransfected tumor cell vaccine, which is labor- and time-consuming in manufacturing, seems to be unsuitable and inconvenient in clinical practice.